智能手表传感器用于帕金森病中震动评估-算法开发和测量属性分析分析
Giulia Palermo Schifino1,2, Maira Jaqueline da Cunha1,2, Ritchele Redivo Marchese1,2
1Movement Analysis and Rehabilitation Laboratory, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre 90050-170, Brazil.
Sensors (Basel, Switzerland)
|July 30, 2025
概括
智能手表可以使用传感器数据检测帕金森病 (PD) 的震. 这项技术为监测PD进展和帮助诊断提供了一个有希望的,可访问的工具.
科学领域:
- 生物医学工程 生物医学工程
- 神经学 神经学
- 可穿戴技术可穿戴技术
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特点是震影响日常生活.
- 可穿戴设备为PD症状的持续,客观监测提供了潜力.
研究的目的:
- 开发和验证使用智能手表传感器用于帕金森病的震动检测算法.
- 评估基于智能手表的震动检测的准确性,可靠性和区分有效性.
主要方法:
- 收集了来自21名PD患者和27名对照者的智能手表 (Apple Watch Series 3) 和商业IMU (G-Sensor) 的同步数据.
- 从传感器信号中提取特征,并应用统计分析以确定有效性和可靠性.
- 在加速仪和陀螺仪数据上利用功率光谱密度 (PSD) 分析来检测震动.
主要成果:
- 该算法显示智能手表和IMU数据之间存在中度至强度的相关性.
- 成功地将患有PD的个人与健康的对照区分开来,与临床措施相关 (MDS-UPDRS III).
- 使用x轴加速度计和陀螺仪数据,PSD分析有效地识别了震动,可靠性的比例偏差得到了注意.
结论:
- 智能手表显示出作为检测帕金森病震的工具的潜力.
- 需要对更大,更受损的队列进行进一步的研究,以确认强度和通用性.
相关概念视频
01:24Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
01:15Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710